This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University. Nephrology Division is NOT responsible for the content of the presentation for it is intended for learning and /or education purpose only.
BY MOHANNAD IBN HOMAID Approach to bleeding Disorders
A few points Content Structure 1 st half 2 nd half
Overview Why is it important ? Why is it so confusing ? Basic Science Clinical manifestations Laboratory tests
Basic Science Review Blood is gold The 2 arms of Heamostasis Platelets Clotting Factors Small Vessel Response To Injury
Normal Response Always Goes Through the following: Vascular Phase Platelet Phase Coagulation Phase Fibronlytic Phase Pointless ? Or useful ?
Vascular Phase Not Very important for understanding Vasoconstriction TXA2 and Aspirin
Platelet Phase
Unfortunately Very important The following occurs: Platelet Adhesion (vWF later) Platelet Release Reaction ADP TXA2 Temporary Plug < < BLEEDING STOPS HERE Bleeding time The Tile
Coagulation Phase
VERY IMPORTANT and VERY CONFUSING Why is it Confusing ? Not Tangible Coagulation Phase and 12 factors Cofactors Ca and PF3 Extrinsic vs intrinsic Vitamin K factors Anti-Thrombin 3 And last but not least….
THE ROMAN NUMBERS
Coagulation Cascade What do you need to know ? Simple Steps : extrinsic vs intrinsic Content of both How to test them Where they are made ( liver ) Vitamin K AT-3
CONFUSING
THIS SLIDE HAS BEEN INTENTIONALLY LEFT BLANK
Extrinsic System: 7 Intrinsic System: Final Common Pathway : Vitamin K : AT-3 : PTT vs PT
Coagulation Studies
Fibrinolytic Phase
Kinnnd of important but very easy Tissue plasminogen Activator Plasmin Test Fibrin Degradation Products D-Dimer Assay
Back to the clinical world Presentation of platelet Defects Blood leaks out of vessels Skin and mucosal surfaces Prolonged bleeding ( temporary plug plug ) Presentation Deep Tissue Bleeding Late Rebleeding ( permanent plug Defect )
Laboratory Test Platlets Count Bleeding Time Aggregation Test Clotting Factors PT and PTT Factor Assay Fibrinolysis FDP D-Dimer
Platelet Disorders Quantitative vs Qualitative Thrombocytopenia Immune Thrombocytopenic Prupura Bernard Soulier Syndrome Glanzmanns Thrombasthenia Thrombotic thrombocytopenic Purpura
Thrombocytopenia Pathology :Increase Destruction or decrease Productions > > Clinical Features : depend on degree Labs: Treatment:
ITP Pathology : Auto antibodies Agains Platlets Clinical Features: Labs: Treatment:
Bernard Soulier Syndrome Pathology :GP1B receptor Defiency Clinical Features: Labs:
Glanzmann Thromboasthenia Pathology :GPIIb-IIIa Defiency Clinical Features: Labs: Treatment:
TTP Pathology :Unkown Clinical Features: Pentad : HUS + Fever Neurological Labs: Treatment :Plasmapharesis
Diorders of Coagulations Hemophilia Von Willebrand Disease
Hemophilia Pathology :Factor 8 or 9 Clinical Features: Acute Hemoarthrosis Intracranial Bleeding Hematomas Labs: Treatment: Factor Replacement DDAVP
Von willebrand Disease Function of vWF Made in platelets and endothelium Adhesion of platelets to exposed Collagen Protection of Circulating Factor 8 Pathology Deficiency of vWF Secondary decrease in Factor 8
Von Willebrand Disease Pathology : Mentioned Clinical Features: Labs: Treatment: 1. DDAVP And factor concentrates
DIC Pathology :Inappropriate Activation of platelets and clotting Factors due to : Sepsis ( 50%) Obstetric Complications Malignancy Trauma Clinical Features: Labs: Treatment: ICU and supportive = Treatment of underlying Cause
Questions